|
|
 | | | |
- close
- close
- close
- close
| |||||||||
These excerpts taken from the TXN 10-K filed Feb 24, 2009. Research and Development
Our primary area of R&D investment is Analog and Embedded Processing products. We conduct most of our R&D internally. However, we also closely engage with a wide range of external industry consortia and universities and collaborate with our foundry suppliers on semiconductor manufacturing technology. From time to time we may terminate R&D projects before completion or decide not to manufacture and sell a developed product. We do not expect that all of our R&D projects will result in products that are ultimately released for sale, or that our projects will contribute significant revenue until at least a few years following completion. Our R&D expense was $1.94 billion in 2008, compared with $2.14 billion in 2007 and $2.20 billion in 2006. Research and Development Our primary area of R&D investment is From time to time we may terminate R&D Our R&D expense was $1.94 billion in These excerpts taken from the TXN 10-K filed Feb 26, 2008. Research and Development Our primary area of R&D investment is semiconductor products and semiconductor manufacturing technology. We conduct most of our R&D internally. However, we also closely engage with a wide range of external industry consortia and universities and collaborate with our foundry suppliers.
8
From time to time we may terminate R&D projects before completion or decide not to manufacture and sell a developed product. We do not expect that all of our R&D projects will result in products that are ultimately released for sale or that our projects will contribute to revenue until at least a few years following completion. Our R&D expense was $2.15 billion in 2007, compared with $2.20 billion in 2006 and $1.99 billion in 2005. Research and Development closely engage with a wide range of external industry consortia and universities and collaborate with our foundry suppliers.
8 From time to time we may terminate R&D projects before completion or decide not to manufacture and sell a developed Our revenue and operating results are subject to The following is an
The term of office of the above-listed officers is from the date of their election until their successor shall This excerpt taken from the TXN 10-K filed Feb 28, 2007. Research and Development Our primary area of R&D investment is semiconductor products and semiconductor manufacturing technology. We conduct most of our R&D internally. However, we also closely engage with a wide range of external industry consortia and universities and collaborate with our foundry suppliers. From time to time we may terminate R&D projects before completion or decide not to manufacture and sell a developed product. We do not expect that all of our R&D projects will result in products that are ultimately released for sale or that our projects will contribute to revenue until at least a few years following completion. Our R&D expense was $2.20 billion in 2006, compared with $1.99 billion in 2005 and $1.95 billion in 2004. This excerpt taken from the TXN 8-K filed Nov 3, 2006. 12. Research and Development R&D expense totaled $1.99 billion in 2005, $1.95 billion in 2004 and $1.72 billion in 2003. Acquisition-related in-process R&D charges were zero in 2005 and 2004, but were $23 million in 2003. The 2003 charges were for R&D from the acquisition of Radia and were recorded in R&D expense. Values for acquisition-related in-process R&D were determined at the acquisition date based upon the appraised value of the related developmental projects. These excerpts taken from the TXN 10-K filed Feb 28, 2006. Research and Development (R&D)
Our primary area of R&D investment is semiconductor products and semiconductor manufacturing technology. We conduct most of our R&D internally. However, we also closely engage with a wide range of external industry consortia and universities.
From time to time we may terminate R&D projects before completion or decide not to manufacture and sell a developed product. We do not expect that all of our R&D projects will result in products that are ultimately released for sale or that our projects will contribute to revenue until at least a few years following completion.
Our R&D expense was $2.02 billion in 2005, compared with $1.98 billion in 2004 and $1.75 billion in 2003. Included is a charge for the value of acquisition-related in-process R&D of zero in 2005 and 2004 and $23 million in 2003.
11. Research and Development R&D expense totaled $2.02 billion in 2005, $1.98 billion in 2004 and $1.75 billion in 2003. Acquisition-related in-process R&D charges were zero in 2005 and 2004, but were $23 million in 2003. The 2003 charges were for R&D from the acquisition of Radia and were recorded in R&D expense. Values for acquisition-related in-process R&D were determined at the acquisition date based upon the appraised value of the related developmental projects. These excerpts taken from the TXN 10-K filed Feb 28, 2005. Research and Development (R&D)
Our primary area of R&D investment is semiconductor products and semiconductor manufacturing technology. We conduct most of our R&D internally. However, we also closely engage with a wide range of external industry consortia and universities.
From time to time we may terminate R&D projects before completion or decide not to manufacture and sell a developed product. We do not expect that all of our R&D projects will result in products that are ultimately released for sale or that our projects will contribute to revenue until at least a few years following completion.
Our R&D expense was $1978 million in 2004, compared with $1748 million in 2003 and $1619 million in 2002. Included is a charge for the value of acquisition-related in-process R&D of zero in 2004, $23 million in 2003, and $1 million in 2002.
11. Research and Development
Research and development (R&D) expense totaled $1978 million in 2004, $1748 million in 2003 and $1619 million in 2002.
Acquisition-related in-process R&D (purchased R&D) charges were zero in 2004, $23 million in 2003 and $1 million in 2002. These charges were for R&D from business purchase acquisitions (2003 related to Radia) and were recorded in R&D expense. Values for purchased R&D were determined at the acquisition date based upon the appraised value of the related developmental projects. Purchased R&D projects were assessed, analyzed and valued using the Exclusion Approach within the context and framework articulated by the Securities and Exchange Commission.
| EXCERPTS ON THIS PAGE:
|
| |||||||
